Skip to main content
Matthew Porembka, MD, General Surgery, Dallas, TX

Matthew Ryan Porembka MD FACS (He/Him)

Hepatobiliary Surgery, Pancreas, Surgical Oncology (Other than Breast), Minimally Invasive Surgery


Associate Professor of Surgery Dedman Family Scholar in Clinical Care

Join to View Full Profile
  • 5323 Harry Hines BoulevardDallas, TX 75390

  • Phone+1 214-645-4673

  • Fax+1 214-645-2542

Dr. Porembka is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 2012 - 2014
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Surgery, 2005 - 2012
  • University of Pittsburgh School of Medicine
    University of Pittsburgh School of MedicineClass of 2005

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2014 - 2026
  • NY State Medical License
    NY State Medical License 2012 - 2015
  • MO State Medical License
    MO State Medical License Active through 2013
  • Surgery
    American Board of Surgery Surgery
  • Complex General Surgical Oncology
    American Board of Surgery Complex General Surgical Oncology

Awards, Honors, & Recognition

  • Fellow Society of Surgical Oncology Society of Surgical Oncology
  • Fellow (FACS) American College of Surgeons

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Adjuvant Therapy Is Associated with Improved Survival in pT1N1 Gastric Cancer in a Heterogeneous Western Patient Population  
    Mathew M Augustine, John C Mansour, Patricio M Polanco, Sam C Wang, Adam C Yopp, Matthew R Porembka, Annals of Surgical Oncology
  • Improved Survival in Surgically Resected Distal Cholangiocarcinoma Treated with Adjuvant Therapy: A Propensity Score Matched Analysis  
    John C Mansour, Mathew Augustine, Sam C Wang, Ibrahim Nassour, Matthew R Porembka, Michael A Choti, Rebecca M Minter, Patricio M Polanco, Adam C Yopp, Journal of gastrointestinal surgery

Press Mentions

  • Newly Developed Nanoparticle Vaccine Immunotherapy Targets Multiple Cancer Types
    Newly Developed Nanoparticle Vaccine Immunotherapy Targets Multiple Cancer TypesApril 25th, 2017

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: